Siga Technologies INC Current Liabilities
Siga Technologies INC (SIGA) had Current Liabilities of $7.85 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:LiabilitiesCurrent · last filed 2026-08-06
- 2026-06-30: Liabilities, Current $7.85M.
- 2026-03-31: Liabilities, Current $65.16M.
- 2025-12-31: Liabilities, Current $17.99M.
- 2025-09-30: Liabilities, Current $24.84M.
| Period end | Liabilities, Current | Liabilities, Current as first filed |
|---|---|---|
| 2026-06-30 | $7.85M 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $65.16M 10-Q · filed 2026-05-07 | |
| 2025-12-31 | $17.99M 10-Q · filed 2026-08-06 | |
| 2025-09-30 | $24.84M 10-Q · filed 2025-11-06 | |
| 2025-06-30 | $22.72M 10-Q · filed 2025-08-05 | |
| 2025-03-31 | $27.80M 10-Q · filed 2025-05-08 | |
| 2024-12-31 | $25.33M 10-K · filed 2026-03-10 | |
| 2024-09-30 | $22.30M 10-Q · filed 2024-11-07 | |
| 2024-06-30 | $21.38M 10-Q · filed 2024-08-01 | |
| 2024-03-31 | $74.81M 10-Q · filed 2024-05-07 | |
| 2023-12-31 | $54.12M 10-K · filed 2025-03-11 | |
| 2023-09-30 | $30.74M 10-Q · filed 2023-11-07 | |
| 2023-06-30 | $18.99M 10-Q · filed 2023-08-08 | |
| 2023-03-31 | $18.48M 10-Q · filed 2023-05-04 | |
| 2022-12-31 | $21.52M 10-K · filed 2024-03-12 | |
| 2022-09-30 | $27.46M 10-Q · filed 2022-11-03 | |
| 2022-06-30 | $16.69M 10-Q · filed 2022-08-04 | |
| 2022-03-31 | $7.24M 10-Q · filed 2022-05-05 | |
| 2021-12-31 | $30.49M 10-K · filed 2023-03-02 | |
| 2021-09-30 | $18.94M 10-Q · filed 2021-11-04 | |
| 2021-06-30 | $7.97M 10-Q · filed 2021-08-05 | |
| 2021-03-31 | $7.51M 10-Q · filed 2021-05-06 | |
| 2020-12-31 | $10.48M 10-K · filed 2022-03-03 | |
| 2020-09-30 | $16.30M 10-Q · filed 2020-11-05 | |
| 2020-06-30 | $15.56M 10-Q · filed 2020-08-06 | |
| 2020-03-31 | $21.42M 10-Q · filed 2020-05-06 | |
| 2019-12-31 | $91.74M 10-K · filed 2021-03-04 | |
| 2019-09-30 | $11.80M 10-Q · filed 2019-11-05 | |
| 2019-06-30 | $11.12M 10-Q · filed 2019-08-06 | |
| 2019-03-31 | $12.11M 10-Q · filed 2019-05-02 | |
| 2018-12-31 | $11.34M 10-K · filed 2020-03-05 | |
| 2018-09-30 | $5.21M 10-Q · filed 2018-11-06 | |
| 2018-06-30 | $381.26M 10-Q · filed 2018-08-07 | |
| 2018-03-31 | $4.02M 10-Q · filed 2018-05-04 | |
| 2017-12-31 | $6.81M 10-K · filed 2019-03-06 | |
| 2017-09-30 | $13.04M 10-Q · filed 2017-11-07 | |
| 2017-06-30 | $13.63M 10-Q · filed 2017-08-03 | |
| 2017-03-31 | $12.56M 10-Q · filed 2017-05-04 | |
| 2016-12-31 | $7.10M 10-K · filed 2018-03-06 | $13.83M 10-K · filed 2017-03-07 |
| 2016-09-30 | $108.33M 10-Q · filed 2016-11-02 | |
| 2016-06-30 | $216.88M 10-Q · filed 2016-08-08 | |
| 2016-03-31 | $13.54M 10-Q · filed 2016-05-04 | |
| 2015-12-31 | $7.33M 10-K · filed 2017-03-07 | |
| 2015-09-30 | $6.24M 10-Q · filed 2015-10-27 | |
| 2015-06-30 | $8.02M 10-Q · filed 2015-08-04 | |
| 2015-03-31 | $6.98M 10-Q · filed 2015-05-06 | |
| 2014-12-31 | $7.46M 10-K · filed 2016-03-04 | |
| 2014-09-30 | $4.59M 10-Q · filed 2014-11-04 | |
| 2014-06-30 | $8.40M 10-Q · filed 2014-07-31 | |
| 2014-03-31 | $11.14M 10-Q · filed 2014-05-01 | |
| 2013-12-31 | $12.19M 10-K · filed 2015-03-06 | |
| 2013-09-30 | $17.25M 10-Q · filed 2013-11-06 | |
| 2013-06-30 | $30.96M 10-Q · filed 2013-08-05 | |
| 2013-03-31 | $15.15M 10-Q · filed 2013-05-15 | |
| 2012-12-31 | $15.76M 10-K · filed 2014-03-10 | $15.72M 10-K · filed 2013-03-06 |
| 2012-09-30 | $15.80M 10-Q · filed 2012-11-05 | |
| 2012-06-30 | $14.51M 10-Q · filed 2012-08-06 | |
| 2012-03-31 | $7.14M 10-Q · filed 2012-05-07 | |
| 2011-12-31 | $7.05M 10-K/A · filed 2013-05-15 | $6.92M 10-K · filed 2012-03-01 |
| 2011-09-30 | $3.70M 10-Q · filed 2011-11-08 | |
| 2011-06-30 | $3.25M 10-Q · filed 2011-08-01 | |
| 2010-12-31 | $4.26M 10-K · filed 2012-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| Pyxis Oncology, Inc. (PYXS) | United States | $0.244B | |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B |